| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,883 | 20,261 | 20,831 | 24,188 | | Cost of Revenue | 3,218 | 3,390 | 3,979 | 5,453 | | | Gross Profit | 17,665 | 16,870 | 16,852 | 18,735 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,341 | 11,534 | 10,162 | 11,236 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,514 | 3,053 | 13,766 | 13,156 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,810 | 2,284 | (7,075) | (5,657) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,810 | 2,284 | (7,075) | (5,657) | | Interest Expense | 749 | 752 | 510 | 623 | | Income Before Tax | 3,061 | 1,532 | (7,586) | (6,280) | | Income Tax Expense | 1,119 | 459 | (2,492) | (2,137) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,941 | 1,072 | (5,093) | (4,144) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,941 | 1,072 | (5,093) | (4,144) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,941 | $1,072 | ($5,093) | ($4,144) |
|
0.11% Nasdaq 
0.09 (1.25%) 
Income Statement
